This article was originally published in The Gray Sheet
Executive SummaryNames Riccardo Pigliucci president, chief operating officer, and a director of the company. A 27-year veteran of the firm, Pigliucci was elected a corporate vice president, Perkin-Elmer Instruments, in 1989 and became a senior vice president in 1992.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.